HEPION PHARMACEUTICALS, INC. Derivative Liability, Noncurrent
HEPION PHARMACEUTICALS, INC. (HEPA) had Derivative Liability, Noncurrent of $156.16 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DerivativeLiabilitiesNoncurrent · last filed 2026-08-13
- 2026-06-30: Derivative Liability, Noncurrent $156.16K.
- 2026-03-31: Derivative Liability, Noncurrent $113.17K.
- 2025-12-31: Derivative Liability, Noncurrent $103.02K.
- 2025-09-30: Derivative Liability, Noncurrent $68.40K.
| Period end | Derivative Liability, Noncurrent |
|---|---|
| 2026-06-30 | $156.16K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $113.17K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $103.02K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $68.40K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $115.68K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $1.49M 10-Q · filed 2025-05-19 |
| 2024-12-31 | $333.19K 10-K · filed 2026-03-12 |
| 2024-09-30 | $1.41M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $1.47M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $4.75M 10-Q · filed 2024-05-21 |
| 2023-12-31 | $3.80M 10-K · filed 2025-04-08 |
| 2022-12-31 | $0.00 10-K · filed 2024-04-16 |
| 2021-12-31 | $0.00 10-K · filed 2022-04-08 |
| 2021-09-30 | $762.00 10-Q · filed 2021-11-15 |
| 2021-06-30 | $3.53K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $5.46K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $11.67K 10-K · filed 2022-04-08 |
| 2020-09-30 | $30.83K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $34.40K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $15.30K 10-Q · filed 2020-06-29 |
| 2019-12-31 | $5.62K 10-K · filed 2021-03-31 |
| 2019-09-30 | $409.00 10-Q · filed 2019-11-14 |
| 2019-06-30 | $8.81K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $208.42K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $404.34K 10-K · filed 2020-05-14 |
| 2018-09-30 | $1.35M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $139.02K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $274.34K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $669.46K 10-K · filed 2019-03-14 |
| 2017-09-30 | $1.61M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $1.70M 10-KT · filed 2018-03-26 |
| 2017-04-25 | $4.00M 10-Q · filed 2018-08-14 |
| 2017-03-31 | $3.91M 10-Q · filed 2017-04-12 |
| 2016-12-31 | $2.37M 10-Q · filed 2017-02-14 |
| 2016-09-30 | $2.06M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $2.12M 10-KT · filed 2018-03-26 |
| 2016-04-04 | $1.50M 10-Q · filed 2018-11-14 |
| 2016-03-31 | $1.17M 10-Q · filed 2016-05-13 |
| 2015-12-31 | $1.90M 10-Q · filed 2016-02-12 |
| 2015-10-13 | $4.40M 10-Q · filed 2018-11-14 |
| 2014-06-30 | $4.48M 10-K · filed 2015-09-25 |
| 2014-03-31 | $9.73M 10-Q · filed 2014-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |